The small end of the Australian share market is home to a number of companies with the potential to grow materially in the future.
Three that investors might want to get better acquainted with are listed below. Here's why they are rated highly:
Image source: Getty Images
Bigtincan Holdings Ltd (ASX: BTH)
The first small cap ASX share to look at is this leading provider of enterprise mobility software to businesses globally. Bigtincan's software provides businesses with new and more effective ways for their teams to perform at higher levels and deliver better results. This is because, as the company notes, its platform empowers sales and service representatives to maximise their use of sales collateral to engage with customers and prospects more effectively.
Morgan Stanley is bullish on Bigtincan. It has an overweight rating and $2.10 price target on its shares.
Symbio Holdings Ltd (ASX: SYM)
Another small cap to watch is Symbio. It specialises in the Voice over Internet Protocol (VoIP) technology which is used to support services like teleconferencing, online business meetings, and digital data transfers. Symbio appears well-placed for growth over the long term thanks to increasing demand for VoIP technology, its expansion into Asia, and its strong balance sheet. The latter gives management opportunities to look at boosting its growth with acquisitions.
Ord Minnett currently has a buy rating and $7.15 price target on Symbio's shares.
Whispir Ltd (ASX: WSP)
A final small cap ASX share to watch is Whispir. It provides a leading software-as-a-service (SaaS) communications workflow platform that automates interactions between organisations and people. Whispir has been growing at a solid rate in recent years and management appears confident this will continue. This is due to the global mega trend of digital transformation which is providing strong tailwinds. Another positive is the low levels of churn the company is reporting (under 2%), which demonstrates the stickiness of its platform.
Ord Minnett is also a fan of Whispir. It has a buy rating and $2.85 price target on its shares.
